富血小板纤维蛋白衍生物的研究进展

doi:10.7518/hxkq.2019.06.016

华西口腔医学杂志 ›› 2019, Vol. 37 ›› Issue (6): 660-665.doi: 10.7518/hxkq.2019.06.016

富血小板纤维蛋白衍生物的研究进展

常尧仁¹,刘纯¹,殷丽华^1,²

^1. 兰州大学口腔医院口腔种植科,兰州 730000
^2. 上海交通大学医学院附属第九人民医院口腔种植科,上海 200011

收稿日期:2019-03-21 修回日期:2019-06-19 出版日期:2019-12-01 发布日期:2019-11-27
通讯作者: 常尧仁
作者简介:常尧仁,硕士,E-mail：changyr11@lzu.edu.cn
基金资助:
中国博士后科学基金(2018M632142);甘肃省省级引导科技创新发展竞争性项目专项资金(2018ZX-10);兰州市人才创新创业项目(2017-RC-31)

Research progress on platelet-rich fibrin derivatives

Chang Yaoren¹,Liu Chun¹,Yin Lihua^1,²

^1. Dept. of Oral Implantation, Hospital of Stomatology, Lanzhou University, Lanzhou 730000, China
^2. Dept. of Dental Implantation, Shanghai Ninth People’s Hospital, Shanghai Jiao Tong University, Shanghai 200011, China

Received:2019-03-21 Revised:2019-06-19 Online:2019-12-01 Published:2019-11-27
Contact: Lihua Yin
Supported by:
China Postdoctoral Science Foundation(2018M632142);Special Fund for Guiding the Development of Competitive Projects in Science and Technology Innovation at the Provincial Level in Gansu Province(2018ZX-10);Lanzhou Talent Innovation and Entrepreneurship Project(2017-RC-31)

摘要/Abstract

摘要：

富血小板血浆和富血小板纤维蛋白（PRF）目前已成熟地应用于口腔医学领域,随着制备技术与基础研究的不断深入,PRF的衍生物也相继出现并应用于口腔临床中。本文就PRF衍生物的演变、制备技术、生物学特性及医学研究进展作一综述。

关键词: 富血小板纤维蛋白衍生物, 制备技术, 生物学特性

Abstract:

Platelet-rich plasma and platelet-rich fibrin (PRF) are widely used in the field of stomatology. Advancements in preparation techniques and basic research have enabled the use of PRF derivatives in oral clinical applications. The evolution, preparation techniques, biological properties, and medical research progress of PRF derivatives are reviewed in this paper.

Key words: platelet-rich fibrin derivatives, preparation technique, biological property

中图分类号:

常尧仁, 刘纯, 殷丽华. 富血小板纤维蛋白衍生物的研究进展[J]. 华西口腔医学杂志, 2019, 37(6): 660-665.

Chang Yaoren, Liu Chun, Yin Lihua. Research progress on platelet-rich fibrin derivatives[J]. West China Journal of Stomatology, 2019, 37(6): 660-665.

参考文献 56

[1]	Dohan DM, Choukroun J, Diss A , et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅰ: technological concepts and evolution[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2006,101(3):e37-e44. doi: 10.1016/j.tripleo.2005.07.008 URL pmid: 16504849
[2]	He L, Lin Y, Hu X , et al. A comparative study of platelet-rich fibrin (PRF) and platelet-rich plasma (PRP) on the effect of proliferation and differentiation of rat osteoblasts in vitro[J]. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 2009,108(5):707-713. doi: 10.1016/j.tripleo.2009.06.044 URL pmid: 19836723
[3]	Plachokova AS, van den Dolder J, Stoelinga PJ , et al. The bone regenerative effect of platelet-rich plasma in combination with an osteoconductive material in rat cranial defects[J]. Clin Oral Implan Res, 2006,17(3):305-311. doi: 10.1111/j.1600-0501.2005.01208.x URL pmid: 16672026
[4]	Dohan Ehrenfest DM, Del Corso M, Diss A , et al. Three-dimensional architecture and cell composition of a Choukroun’s platelet-rich fibrin clot and membrane[J]. J Periodontol, 2010,81(4):546-555. doi: 10.1902/jop.2009.090531 URL
[5]	Dohan DM, Choukroun J, Diss A , et al. Platelet-rich fibrin (PRF): a second-generation platelet concentrate. Part Ⅲ: leucocyte activation: a new feature for platelet concentrates[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2006,101(3):e51-e55. doi: 10.1016/j.tripleo.2005.07.010 URL pmid: 16504851
[6]	Dohan Ehrenfest DM, de Peppo GM, Doglioli P , et al. Slow release of growth factors and thrombospondin-1 in Choukroun’s platelet-rich fibrin (PRF): a gold standard to achieve for all surgical platelet concentrates technologies[J]. Growth Factors, 2009,27(1):63-69. doi: 10.1080/08977190802636713 URL
[7]	Dohan Ehrenfest DM, Diss A, Odin G , et al. In vitro effects of Choukroun’s PRF (platelet-rich fibrin) on human gingival fibroblasts, dermal prekeratinocytes, preadipocytes, and maxillofacial osteoblasts in primary cultures[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2009,108(3):341-352. doi: 10.1016/j.tripleo.2009.04.020 URL pmid: 19589702
[8]	Dohan Ehrenfest DM ,Doglioli P,de Peppo GM, et al. Choukroun’s platelet-rich fibrin (PRF) stimulates in vitro proliferation and differentiation of human oral bone mesenchymal stem cell in a dose-dependent way[J]. Arch Oral Biol, 2010,55(3):185-194. doi: 10.1016/j.archoralbio.2010.01.004 URL
[9]	Dohan Ehrenfest DM, Rasmusson L, Albrektsson T . Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to leucocyte- and platelet-rich fibrin (L-PRF)[J]. Trends Biotechnol, 2009,27(3):158-167. doi: 10.1016/j.tibtech.2008.11.009 URL
[10]	O’Connell SM . Safety issues associated with platelet-rich fibrin method[J]. Oral Surg Oral Med Oral Pathol Oral Radiol, 2007,103(5):587. doi: 10.1016/j.tripleo.2007.03.017 URL pmid: 17466883
[11]	Tunali M, Özdemir H ,Küçükodaci Z , et al. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate[J]. Br J Oral Maxillofac Surg, 2013,51(5):438-443. doi: 10.1016/j.bjoms.2012.08.003 URL pmid: 22951383
[12]	Tunali M, Ozdemir H, Kucukodaci Z , et al. Titanium prepared platelet-rich fibrin (TPRF): a third-generation patelet concentrate. A pilot study[J]. J Clin Periodontol, 2012,39(1):126.
[13]	Choukroun J . Advanced PRF & i-PRF: platelet concentrates or blood concentrates[J]. J Periodont Med Clin Pract, 2014,1(1):3. doi: 10.1186/s13104-019-4750-x URL pmid: 31685012
[14]	Lucarelli E, Beretta R, Dozza B , et al. A recently developed bifacial platelet-rich fibrin matrix[J]. Eur Cell Mater, 2010,20(1):13-23. doi: 10.22203/ecm.v020a02 URL pmid: 20597062
[15]	Zhang DS, Eggleton CD, Arola DD . Evaluating the mechanical behavior of arterial tissue using digital image correlation[J]. Exp Mech, 2002,42(4):409-416. doi: 10.1007/BF02412146 URL
[16]	Zhang GA, Ning FG, Zhao NM . Biomechanical properties of four dermal substitutes[J]. Chin Med J, 2007,120(16):1454-1455. URL pmid: 17825178
[17]	Mazzucco L, Balbo V, Cattana E , et al. Not every PRP-gel is born equal Evaluation of growth factor availability for tissues through four PRP-gel preparations: Fibrinet ^®, RegenPRP-Kit ^®, Plateltex ^® and one manual procedure [J]. Vox Sanguinis, 2009,97(2):110-118. doi: 10.1111/j.1423-0410.2009.01188.x URL pmid: 19392780
[18]	O’Connell SM, Impeduglia T, Hessler K , et al. Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers[J]. Wound Repair Regen, 2008,16(6):749-756. doi: 10.1111/j.1524-475X.2008.00426.x URL pmid: 19128245
[19]	Dohan Ehrenfest DM, Pinto NR, Pereda A , et al. The impact of the centrifuge characteristics and centrifugation protocols on the cells, growth factors, and fibrin architecture of a leukocyte- and platelet-rich fibrin (L-PRF) clot and membrane [J]. Platelets, 2018,29(2):171-184. doi: 10.1080/09537104.2017.1293812 URL pmid: 28437133
[20]	Mazzucco L, Balbo V, Cattana E , et al. Platelet-rich plasma and platelet gel preparation using Plateltex ^® [J]. Vox Sanguinis, 2008,94(3):202-208. doi: 10.1111/j.1423-0410.2007.01027.x URL pmid: 18179680
[21]	Masuki H, Okudera T, Watanebe T , et al. Growth factor and pro-inflammatory cytokine contents in platelet-rich plasma (PRP), plasma rich in growth factors (PRGF), advanced platelet-rich fibrin (A-PRF), and concentrated growth factors (CGF)[J]. Int J Implant Dent, 2016. doi. org/10.1186/s40729-016-0052-4. doi: 10.1186/s40729-019-0192-4 URL pmid: 31749041
[22]	Fujioka-Kobayashi M, Miron RJ, Hernandez M , et al. Optimized platelet-rich fibrin with the low-speed concept: growth factor release, biocompatibility, and cellular response[J]. J Periodontol, 2017,88(1):112-121. doi: 10.1902/jop.2016.160443 URL pmid: 27587367
[23]	Miron RJ, Fujioka-Kobayashi M, Hernandez M , et al. Injectable platelet rich fibrin (i-PRF): opportunities in regenerative dentistry[J]. Clin Oral Invest, 2017,21(8):2619-2627. doi: 10.1007/s00784-017-2063-9 URL pmid: 28154995
[24]	Mourão CF, Valiense H, Melo ER , et al. Obtention of injectable platelets rich-fibrin (i-PRF) and its polymerization with bone graft: technical note[J]. Rev Col Bras Cir, 2015,42(6):421-423. doi: 10.1590/0100-69912015006013 URL pmid: 26814997
[25]	Tunali M, Özdemir H, Küçükodacı Z , et al. In vivo evaluation of titanium-prepared platelet-rich fibrin (T-PRF): a new platelet concentrate[J]. Br J Oral Maxillofac Surg, 2013,51(5):438-443. doi: 10.1016/j.bjoms.2012.08.003 URL pmid: 22951383
[26]	Tunali M, Özdemir H ,Küçükodacı Z, et al. A novel platelet concentrate: titanium-prepared platelet-rich fibrin[J]. Biomed Res Int, 2014,2014:1-7. doi: 10.4103/JCD.JCD_216_18 URL pmid: 30820078
[27]	Aggour RL, Sabry HA, Hassan GS . In vitro evaluation of mechanical and structural properties of leukocyte-platelet-rich fibrin and platelet-rich fibrin martix[J]. Egypt Dent J, 2017,63(2):305-313.
[28]	Simon B, Zatcoff A, Kong JJ , et al. Clinical and histological comparison of extraction socket healing following the use of autologous platelet-rich fibrin matrix (PRFM) to ridge preservation procedures employing demineralized freeze dried bone allograft material and membrane[J]. Open Dent J, 2009,3(1):92-99. doi: 10.2174/1874210600903010092 URL
[29]	Simon BI, Gupta P, Tajbakhsh S . Quantitative evaluation of extraction socket healing following the use of autologous platelet-rich fibrin matrix in humans[J]. Int J Periodont Restorat Dent, 2011,31(3):285-295. URL pmid: 21556385
[30]	O’Connell SM, Hessler K, Dardik H . Cascade ^® autologous system platelet-rich fibrin matrix in the treatment of chronic leg ulcers [J]. Adv Wound Care, 2012,1(1):52-55. doi: 10.1089/wound.2011.0290 URL
[31]	Dohan Ehrenfest DM, Bielecki T, Jimbo R , et al. Do the fibrin architecture and leukocyte content influence the growth factor release of platelet concentrates? An evidence-based answer comparing a pure platelet-rich plasma (P-PRP) gel and a leukocyte- and platelet-rich fibrin (L-PRF)[J]. Curr Pharma Biotech, 2012,13(7):1145-1152. doi: 10.2174/138920112800624382 URL pmid: 21740377
[32]	Lollobrigida M, Maritato M, Bozzuto G , et al. Biomimetic implant surface functionalization with liquid L-PRF products: in vitro study[J]. Biomed Res Int, 2018. doi. org/10.1155/2018/9031435. doi: 10.1155/2019/9824964 URL pmid: 31737682
[33]	Öncü E, Bayram B, Kantarcı A , et al. Positive effect of platelet rich fibrinon osseointegration[J]. Med Oral Patol Oral Cir Bucal, 2016,21(5):e601. doi: 10.4317/medoral.21026 URL pmid: 27475686
[34]	Neiva RF, Gil LF, Tovar N , et al. The synergistic effect of leukocyte platelet-rich fibrin and micrometer/nanometer surface texturing on bone healing around immediately placed implants: an experimental study in dogs[J]. Biomed Res Int, 2016,2016:1-9. doi: 10.1155/2016/9507342 URL pmid: 28042577
[35]	Bastami F, Khojasteh A . Use of leukocyte-and platelet-rich fibrin for bone regeneration: a systematic review[J]. Regen Reconstr Restor, 2016,1(2):47-68. doi: 10.1155/2019/9148183 URL pmid: 31531371
[36]	del Corso M, Sammartino G, Dohan Ehrenfest DM . Letter to the editor: Re: “clinical evaluation of a modified coronally advanced flap alone or in combination with a platelet-rich fibrin membrane for the treatment of adjacent multiple gingival recessions: a 6-month study”[J]. J Periodontol, 2009,80(11):1694-1697. doi: 10.1902/jop.2009.090253 URL pmid: 19905939
[37]	Temmerman A, Cleeren GJ, Castro AB , et al. L-PRF for increasing the width of keratinized mucosa around implants: a split-mouth, randomized, controlled pilot clinical trial[J]. J Periodont Res, 2018,53(5):793-800. doi: 10.1111/jre.12568 URL pmid: 29858875
[38]	Kim JW, Kim SJ, Kim MR . Leucocyte-rich and platelet-rich fibrin for the treatment of bisphosphonate-related osteonecrosis of the jaw: a prospective feasibility study[J]. Br J Oral Maxillofac Surg, 2014,52(9):854-859. doi: 10.1016/j.bjoms.2014.07.256 URL pmid: 25138613
[39]	Ghanaati S, Booms P, Orlowska A , et al. Advanced platelet-rich fibrin: a new concept for cell-based tissue engineering by means of inflammatory cells[J]. J Oral Implant, 2014,40(6):679-689. doi: 10.1563/aaid-joi-D-14-00138 URL pmid: 24945603
[40]	Cabaro S ,D’Esposito V, Gasparro R,et al. White cell and platelet content affects the release of bioactive factors in different blood-derived scaffolds[J]. Platelets, 2018,29(5):463-467. doi: 10.1080/09537104.2017.1319046 URL pmid: 28635382
[41]	Titirinli K, Tekin U, Atıl F , et al. Evaluation of advanced platelet rich fibrin (A-PRF) on bone healing. is it better than old version? A histological animal study[J]. J Biomater Tissue Eng, 2017,7(6):478-483. doi: 10.1166/jbt.2017.1592 URL
[42]	Kalash S, Aboelsaad N, Shokry M , et al. The efficiency of using advanced PRF-xenograft mixture around immediate implants in the esthetic zone: a randomized controlled clinical trial[J]. J Osseointegrat, 2017,9(4):317-322.
[43]	Sameera S, Nagasri M, Aravind Kumar P , et al. Comparison of two surgical techniques in the treatment of multiple gingival recessions sandwiched with a combination of A-PRF and L-PRF[J]. Saudi Dent J, 2018,30(3):183-189. doi: 10.1016/j.sdentj.2018.03.002 URL pmid: 29942101
[44]	Varela HA, Souza JC, Nascimento RM , et al. Injectable platelet rich fibrin: cell content, morphological, and protein characterization[J]. Clin Oral Investig, 2019,23(3):1309-1318. doi: 10.1007/s00784-018-2555-2 URL pmid: 30003342
[45]	Wang XZ, Zhang YF, Choukroun J , et al. Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP[J]. Int J Mol Sci, 2017,18(2):331. doi: 10.1002/prp2.546 URL pmid: 31763045
[46]	Wang XZ, Zhang YF, Choukroun J , et al. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma[J]. Platelets, 2018,29(1):48-55. doi: 10.1080/09537104.2017.1293807 URL pmid: 28351189
[47]	Abd El Raouf M, Wang XZ, Miusi S , et al. Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma[J]. Platelets, 2017,30(2):213-221. doi: 10.1080/09537104.2017.1401058 URL pmid: 29240523
[48]	Miron RJ, Bishara M, Choukroun J . Basics of platelet-rich fibrin therapy[J]. Dent Today, 2017,36(4):74-76. URL pmid: 29235312
[49]	Santos JC, Cruz Tórtora GD, Andrade CF , et al. Reconstruction of atrophic maxilla with the use of allogenic bone graft and platelet concentrate—clinical case report[J]. RSBO, 2018,1(4):238-243. doi: 10.21726/rsbo.v1i4.551 URL
[50]	Chenchev IL, Ivanova VV, Neychev DZ , et al. Application of platelet-rich fibrin and injectable platelet-rich fibrin in combination of bone substitute material for alveolar ridge augmentation—a case report[J]. Folia Medica, 2017,59(3):362-366. doi: 10.1515/folmed-2017-0044 URL pmid: 28976904
[51]	Karde P, Sethi K, Mahale S , et al. Comparative evaluation of platelet count and antimicrobial efficacy of injectable platelet-rich fibrin with other platelet concentrates: an in vitro study[J]. J Indian Soc Periodontol, 2017,21(2):97-101. doi: 10.4103/jisp.jisp_201_17 URL pmid: 29398852
[52]	Takemoto S, Yamamoto T, Tsuru K , et al. Platelet adhesion on titanium oxide gels: effect of surface oxidation[J]. Biomaterials, 2004,25(17):3485-3492. doi: 10.1016/j.biomaterials.2003.10.070 URL
[53]	Tunali M, Özdemir H ,Küçükodac Z, et al. Role of vascular endothelial growth factor and alkaline phosphatase in T-prf induced bone formation[J]. Clin Oral Implant Res, 2014,25(suppl 10):274. doi: 10.1111/clr.12458_1 URL pmid: 25244660
[54]	Firatli E, Tunali M, Özdemir H , et al. Osteopontin expression in T-prf induced bone formation[J]. Clin Oral Implant Res, 2014,25(suppl 10):275. doi: 10.1111/clr.12458_1 URL pmid: 25244660
[55]	Uzun BC, Ercan E, Tunalı M . Effectiveness and predictability of titanium-prepared platelet-rich fibrin for the management of multiple gingival recessions[J]. Clin Oral Investig, 2017. doi. org/10.1007/s00784-017-2211-2. doi: 10.1007/s00784-019-03122-5 URL pmid: 31760476
[56]	Choukroun J, Ghanaati S . Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: the first introduction to the low speed centrifugation concept[J]. Eur J Trauma Emerg Surg, 2018,44(1):87-95. doi: 10.1007/s00068-017-0767-9 URL pmid: 28283682

富血小板纤维蛋白衍生物的研究进展

Research progress on platelet-rich fibrin derivatives

RichHTML

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献 56

相关文章 3

编辑推荐

Metrics

本文评价

[1]	王寅1，2 李龙江3 徐克4 吕品2 郑文龙5. 微小核糖核酸-21对人舌鳞状细胞癌细胞系生物学特性的影响[J]. 华西口腔医学杂志, 2012, 30(4): 350-355.
[2]	郭维华李松徐芸. 不同静压力对大鼠髁突软骨细胞生物学特性的影响[J]. 华西口腔医学杂志, 2007, 25(06): 603-605.
[3]	孙春晓,何荣根,张志愿,刘兴坤,周晓健,陈诗书. HSV-tk基因转导对涎腺腺样囊性癌细胞生物学特性的影响[J]. , 1999, 17(04): 0-.